• Cadila Healthcare reported a 5% quarter-on-quarter (QoQ) decline in its revenues for the quarter ended September (Q2FY22). On a year-on-year (YoY) basis, the same grew by 4%.
  • Its expenses for the quarter were down by 5% QoQ and 2% YoY basis.
  • While the pharma major’s net profit was updown 10% QoQ during Q2FY22, it increased by 15% on a YoY basis.
  • The earnings per share (EPS) of Cadila Healthcare stood at 4.9 during Q2FY22.

Cadila Healthcare’s Financial Statements for Q2FY22:

(Rs, crores) Q2FY21 Q1FY22 Q2FY22 QoQ (%) YoY (%)
Total Income 3,686 4,057 3,838 -5% 4%
Total Expenses 3,065 3,302 3,139 -5% 2%
Profit before tax 490 755 604 -20% 23%
Tax 100 142 100 -29% 0%
Profit after tax 439 565 506 -10% 15%
Earnings per share 4.3 5.5 4.9    

Data Source: BSE, Company announcements

Want to get more analysis on Indian listed companies? Open an account and get daily stock research updates from Kotak Securities.

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results